menu
    • menu

    Company profile for Argenx

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. We are focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need. Our ability to ...
    argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. We are focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need. Our ability to execute on this focus is enabled by our suite of differentiated technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ArgenxNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Laarderhoogtweg 25 1101 EB Amsterdam
    Telephone
    Telephone
    +32 9 310 34 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.argenx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Argenx Updates Uplight Studies in Thyroid Eye Disease
    Argenx Updates Uplight Studies in Thyroid Eye Disease

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205093/0/en/argenx-Provides-Update-on-UplighTED-Studies-of-Efgartigimod-SC-in-Thyroid-Eye-Disease.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Argenx Announces Results of Extraordinary General Meeting
    Argenx Announces Results of Extraordinary General Meeting

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190471/0/en/argenx-Announces-Results-of-Extraordinary-General-Meeting-of-Shareholders.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Argenx Unveils Q3 2025 Financials and Business Update
    Argenx Unveils Q3 2025 Financials and Business Update

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177052/0/en/argenx-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Argenx lays out details on Vyvgart's seronegative gMG win
    Argenx lays out details on Vyvgart's seronegative gMG win

    30 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/argenx-pulls-back-curtain-vyvgarts-seronegative-win-cmo-underlines-mission-leave-no

    FIERCE PHARMA
    30 Oct 2025
    Share Share
    Argenx To Report Q3 2025 Financial Results On October 30
    Argenx To Report Q3 2025 Financial Results On October 30

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171654/0/en/argenx-to-Report-Third-Quarter-2025-Financial-Results-and-Business-Update-on-October-30-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Argenx Showcases Immunology Innovation At 2025 AANEM Meeting
    Argenx Showcases Immunology Innovation At 2025 AANEM Meeting

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3166778/0/en/argenx-to-Highlight-Key-Data-and-Breadth-of-Immunology-Innovation-at-2025-AANEM-Annual-Meeting-and-MGFA-Scientific-Session.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search